GovWhitePapers Logo

Sorry, your browser is not compatible with this application. Please use the latest version of Google Chrome, Mozilla Firefox, Microsoft Edge or Safari.

Artificial Intelligence/Machine Learning-Based Software as a Medical Device Action Plan

This AI/ML-Based Software as a Medical Device Action Plan was developed in direct response to the stakeholder feedback described herein, and it builds on the Agency’s longstanding commitment to support innovative work in the regulation of medical device software and other digital health technologies. In order to continue to advance the concepts from the AI/ML discussion paper toward a practical oversight of AI/ML-based SaMD and of the field in general, the Agency has updated the plan.

 

  • Author(s):
  • FDA Center for Devices and Radiological Health
  • Share this:
  • Share on Facebook
  • Share on Twitter
  • Share via Email
  • Share on LinkedIn
Artificial Intelligence/Machine Learning-Based Software as a Medical Device Action Plan
Format:
  • White Paper
Topics:
Website:Visit Publisher Website
Publisher:U.S. Food & Drug Administration (FDA)
Published:January 1, 2021
License:Public Domain

Featured Content

Contact Publisher

Claim Content